Splenic marginal zone lymphoma in a HIV-1 infected patient: Evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis

Infection

Volumn 41, Issue 1, 2013, Pages 255-258

  Cagliuso, M ^a   Conti, V ^a   Trasarti, S ^a   Lombardi, L ^a   Riminucci, M ^b   Perez, M ^c   Turriziani, O ^b   Falasca, F ^b   Nanni, M ^a   Tafuri, A ^a   Mezzaroma, I ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

HIV 1; SMZLs; Splenomegaly

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; HEMOGLOBIN; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; STAVUDINE; TENOFOVIR; TENOFOVIR DISOPROXIL; VIRUS DNA; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; FEMALE; FEVER; FOLLOW UP; GENE AMPLIFICATION; HEMOGLOBIN BLOOD LEVEL; HEPATOSPLENOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LIMIT OF DETECTION; LYMPHOCYTE COUNT; PANCYTOPENIA; PNEUMOCYSTIS PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLENECTOMY; SPLENIC MARGINAL ZONE LYMPHOMA; THROMBOCYTE COUNT; UNSPECIFIED SIDE EFFECT; VIRUS CARCINOGENESIS; VIRUS LOAD;

CELL TRANSFORMATION, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED; SPLEEN; SPLENIC NEOPLASMS;

EID: 84873709298     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0344-4     Document Type: Article

References (13)

1. Thiele J, Zirbes TK, Bertsch HP, Titius BR, Lorenzen J, Fischer R. AIDS-related bone marrow lesions-myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Ann Cell Pathol. 1996;11:141-57.
2. Tripathi AK, Misra R, Kalra P, Gupta N, Ahmad R. Bone marrow abnormalities in HIV disease. J Assoc Physicians India. 2005;53:705.
3. Isaacson PG, Piris MA, Berger F, Swerdlow SH, Thieblemont C, Pittaluga S, Harris NL. Splenic B-cell marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 185-7.
4. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA. 2002;99:15584-9.
5. Riva E, Pistello M, Narciso P, D'Offizi G, Isola P, Galati V, Turriziani O, Tozzi V, Vincenzi L, Dianzani F, Antonelli G. Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy. AIDS Res Hum Retrovir. 2001;17:1599-603.
6. Navarro WH, Kaplan LD. AIDS-related lymphoproliferative disease. Blood. 2006;107:13.
7. Levine A, Sadeghi S, Espina B, Tulpule A, Nathwani B. Characteristics of indolent non-Hodgkin's lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer. 2002;94:1500-6.
8. McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Hutchison RE, Murphy SB. Molecular and virologic characteristics of lymphoid malignancies in children with AIDS. J Acquir Immune Defic Syndr. 2000;23:152-9.
9. Traverse-Glehen A, Baseggio L, Salles G, Felman P, Berger F. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification. Curr Opin Oncol. 2011;23:441-8.
10. Arcaini L, Sacchi P, Jemos V, Lucioni M, Rumi E, Dionigi P, Paulli M. Splenic marginal zone B-cell lymphoma in a HIV-positive patient: a case report. Ann Hematol. 2009;88:379-1604.
11. Withehead A, Noy A. Successful treatment of marginal zone lymphoma with splenectomy alone despite HIV infection. AIDS. 2007;21:1655-6.
12. Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. Expression of the human immunodeficiency Virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999;94:275-82.
13. Giagulli C, Marsico S, Magiera AK, Bruno R, Caccuri F, Barone I, Fiorentini S, Andò S, Caruso A. Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS ONE. 2011;6:e17831.